Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.bibcol.com | |
Market Cap | 122.11 Cr. | |
Enterprise Value(EV) | 187.57 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -3.85 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-03 |
Industry PE | 41.54 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | -7.54 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | -3.75 | Calculated using Price: 28.28 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 4.32 Cr. | 43,180,000 Shares |
FaceValue | 10 | |
About Bharat Immunologicals & Biologicals Corporation Ltd. | ||
The Company's principal activity is to manufacture and supply of oral polio vaccine. It supplies oral polio vaccine to Government of India. Its plant is located in Bulandshahr, Uttar Pradesh. |
1 Day |
|
-1.46% |
1 Week |
|
+2.69% |
1 Month |
|
-13.06% |
3 Month |
|
-20.61% |
6 Month |
|
+16.28% |
1 Year |
|
+26.42% |
2 Year |
|
-13.91% |
5 Year |
|
+277.07% |
10 Year |
|
+225.06% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 3.81 | -16.25 | 16.94 | -10.76 | -17 | -39.93 | -158.64 | 0 | 0 | |
Return on Capital Employed (%) | 9.07 | -8.52 | 31.11 | -17.52 | -10.7 | -21.87 | -73.05 | -8.08 | -25.63 | |
Return on Assets (%) | 1.81 | -8.5 | 10.8 | -8.51 | -7.22 | -8.97 | -18.41 | -6.35 | -9.41 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 41 | 35 | 42 | 38 | 31 | 20 | 34 | 105 | 88 | 79 | |
Non Curr. Liab. | 4 | 1 | -1 | -5 | -4 | -8 | -14 | -15 | -20 | -19 | |
Curr. Liab. | 35 | 30 | 14 | 13 | 88 | 101 | 64 | 101 | 94 | 99 | |
Minority Int. | |||||||||||
Equity & Liab. | 80 | 66 | 55 | 45 | 115 | 113 | 84 | 192 | 162 | 158 | |
Non Curr. Assets | 7 | 6 | 8 | 7 | 16 | 20 | 50 | 126 | 126 | 126 | |
Curr. Assets | 74 | 60 | 47 | 38 | 99 | 93 | 34 | 65 | 36 | 33 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 80 | 66 | 55 | 45 | 115 | 113 | 84 | 192 | 162 | 158 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 146 | 128 | 124 | 35 | 84 | 67 | 85 | 78 | 45 | 26 | |
Other Income | 1 | 1 | 1 | 1 | 4 | 1 | 2 | 1 | 1 | 1 | |
Total Income | 147 | 129 | 125 | 36 | 88 | 68 | 87 | 79 | 46 | 27 | |
Total Expenditure | -143 | -132 | -111 | -43 | -93 | -77 | -106 | -83 | -61 | -43 | |
PBIDT | 4 | -3 | 14 | -7 | -5 | -9 | -19 | -4 | -15 | -16 | |
Interest | -1 | -6 | -4 | -1 | -2 | -5 | -5 | -6 | -7 | -7 | |
Depreciation | -1 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | -1 | 3 | -3 | 4 | 2 | 4 | 6 | 1 | 6 | 6 | |
Exceptional Items | |||||||||||
PAT | 2 | -6 | 7 | -4 | -6 | -10 | -18 | -9 | -17 | -17 | |
Adjusted EPS | 0 | -1 | 2 | -1 | -1 | -2 | -4 | -2 | -4 | -4 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | -12 | 8 | -9 | -17 | 3 | -32 | 34 | 12 | -42 | 11 | |
Cash Fr. Inv. | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | |
Cash Fr. Finan. | -6 | -1 | -2 | -3 | -3 | 31 | -34 | -12 | 45 | -15 | |
Net Change | -18 | 7 | -10 | -20 | 1 | -1 | 1 | 0 | 3 | -3 | |
Cash & Cash Eqvt | 23 | 30 | 20 | 0 | 1 | 0 | 1 | 1 | 5 | 1 |
Thu, 29 Feb 2024
Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBI'S LODR. BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 08th March 2024 for General Purpose. |
Wed, 13 Dec 2023
Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Scheduled On 29.12.2023. Submission of Draft Annual Report 2022-23 for AGM on 29.12.2023 |
Tue, 28 Nov 2023
Submission Of Notice Of 34Th Annual General Meeting On 29.12.2023 As Compliance Of The Provision Of LODR 2015. Annual General Meeting of Shareholders for the year 2022-23 is scheduled to be held on 29.12.2023.Submitted for kind information and record please. |
Thu, 28 Mar 2024 |
Closing Below Previous Low |
Close Below Last Month Low |
Closing Below Previous Low for 2 Days |
Making Lower Lows for 2 Days |
High Decrease in 1 Month |